AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Date Action Amount Person Type
May 02, 2024 Buy 67 700 Babler Martin Stock Option (Right to Buy)
Apr 13, 2024 Buy 0 Babler Martin
Apr 11, 2024 Buy 1 408 450 Ra Capital Management, L.p. Common Stock
Apr 11, 2024 Sell 2 816 900 Ra Capital Management, L.p. Warrants (Right to Buy)
Apr 01, 2024 Buy 25 000 Palekar Rohan Common Stock
Apr 01, 2024 Sell 52 718 Palekar Rohan Common Stock
Apr 01, 2024 Sell 25 000 Palekar Rohan Stock Option (Right to Buy)
Mar 04, 2024 Buy 1 350 000 Ra Capital Management, L.p. Common Stock
Feb 26, 2024 Sell 4 477 Palekar Rohan Common Stock
Feb 17, 2024 Sell 778 Martins Ryan Common Stock
Feb 17, 2024 Sell 4 602 Palekar Rohan Common Stock
Feb 17, 2024 Sell 1 046 Le-nguyen Quoc Common Stock
Feb 17, 2024 Sell 1 046 Mansbach Harry H Common Stock
Feb 09, 2024 Sell 3 568 Martins Ryan Common Stock
Feb 09, 2024 Sell 3 568 Mansbach Harry H Common Stock
Feb 09, 2024 Sell 3 568 Le-nguyen Quoc Common Stock
Feb 09, 2024 Sell 12 670 Palekar Rohan Common Stock
Feb 05, 2024 Sell 1 190 Mansbach Harry H Common Stock
Feb 05, 2024 Sell 1 190 Le-nguyen Quoc Common Stock
Feb 05, 2024 Sell 5 068 Palekar Rohan Common Stock
Feb 05, 2024 Sell 892 Martins Ryan Common Stock
Feb 01, 2024 Buy 45 150 Ra Capital Management, L.p. Stock Option (Right to Buy)
Feb 01, 2024 Buy 195 000 Mansbach Harry H Stock Option (Right to Buy)
Feb 01, 2024 Buy 48 750 Mansbach Harry H Common Stock
Feb 01, 2024 Buy 48 750 Le-nguyen Quoc Common Stock
Feb 01, 2024 Buy 195 000 Le-nguyen Quoc Stock Option (Right to Buy)
Feb 01, 2024 Buy 45 150 Hayden Michael R Stock Option (Right to Buy)
Feb 01, 2024 Buy 45 150 Dirocco Derek Stock Option (Right to Buy)
Feb 01, 2024 Buy 605 000 Palekar Rohan Stock Option (Right to Buy)
Feb 01, 2024 Buy 150 000 Palekar Rohan Common Stock
Feb 01, 2024 Buy 45 150 Atkinson Edward Morrow Iii Stock Option (Right to Buy)
Feb 01, 2024 Buy 45 150 Laporte Kathleen Stock Option (Right to Buy)
Feb 01, 2024 Buy 45 150 Altschuler Steven Stock Option (Right to Buy)
Feb 01, 2024 Buy 45 150 Zoth Lota S. Stock Option (Right to Buy)
Feb 01, 2024 Buy 175 000 Martins Ryan Stock Option (Right to Buy)
Feb 01, 2024 Buy 48 750 Martins Ryan Common Stock
Jan 05, 2024 Buy 25 000 Mansbach Harry H Common Stock
Jan 05, 2024 Sell 9 671 Mansbach Harry H Common Stock
Jan 05, 2024 Buy 15 000 Martins Ryan Common Stock
Jan 05, 2024 Sell 6 124 Martins Ryan Common Stock
Jan 05, 2024 Buy 25 000 Le-nguyen Quoc Common Stock
Jan 05, 2024 Sell 9 671 Le-nguyen Quoc Common Stock
Jan 05, 2024 Buy 75 000 Palekar Rohan Common Stock
Jan 05, 2024 Sell 27 511 Palekar Rohan Common Stock
Dec 29, 2023 Buy 50 000 Palekar Rohan Common Stock
Dec 29, 2023 Sell 50 000 Palekar Rohan Common Stock
Dec 29, 2023 Sell 50 000 Palekar Rohan Stock Option (Right to Buy)
Dec 11, 2023 Buy 1 081 081 Ra Capital Management, L.p. Pre-Funded Warrants (Right to Buy)
Sep 09, 2023 Sell 3 821 Mansbach Harry H Common Stock
Sep 09, 2023 Sell 2 074 Martins Ryan Common Stock
Sep 09, 2023 Sell 4 958 Le-nguyen Quoc Common Stock
Aug 17, 2023 Sell 1 014 Mansbach Harry H Common Stock
Aug 17, 2023 Sell 4 501 Palekar Rohan Common Stock
Aug 17, 2023 Sell 753 Martins Ryan Common Stock
Aug 01, 2023 Sell 577 Mansbach Harry H Common Stock
Aug 01, 2023 Sell 346 Martins Ryan Common Stock
Aug 01, 2023 Sell 577 Le-nguyen Quoc Common Stock
Aug 01, 2023 Sell 1 014 Le-nguyen Quoc Common Stock
Jul 17, 2023 Sell 12 500 Laporte Kathleen Stock Option (Right to Buy)
Jul 17, 2023 Buy 12 500 Laporte Kathleen Common Stock
Jul 17, 2023 Sell 12 500 Laporte Kathleen Common Stock
Jun 30, 2023 Buy 8 334 Mansbach Harry H Common Stock
Jun 30, 2023 Sell 2 882 Mansbach Harry H Common Stock
Jun 30, 2023 Buy 8 334 Le-nguyen Quoc Common Stock
Jun 30, 2023 Sell 2 882 Le-nguyen Quoc Common Stock
Jun 30, 2023 Buy 33 334 Palekar Rohan Common Stock
Jun 30, 2023 Sell 16 527 Palekar Rohan Common Stock
Jun 30, 2023 Buy 5 834 Martins Ryan Common Stock
Jun 30, 2023 Sell 2 018 Martins Ryan Common Stock
Jun 05, 2023 Buy 15 000 Palekar Rohan Common Stock
Jun 05, 2023 Sell 15 000 Palekar Rohan Common Stock
Jun 05, 2023 Sell 15 000 Palekar Rohan Stock Option (Right to Buy)
Jun 01, 2023 Buy 6 250 Atkinson Edward Morrow Iii Common Stock
Jun 01, 2023 Sell 6 250 Atkinson Edward Morrow Iii Common Stock
Jun 01, 2023 Sell 6 250 Atkinson Edward Morrow Iii Stock Option (Right to Buy)
May 09, 2023 Buy 18 626 Le-nguyen Quoc Common Stock
May 09, 2023 Sell 13 683 Le-nguyen Quoc Common Stock
May 09, 2023 Buy 60 945 Le-nguyen Quoc Common Stock
May 09, 2023 Sell 60 945 Le-nguyen Quoc Stock Option (Right to Buy)
May 09, 2023 Sell 18 626 Le-nguyen Quoc Stock Option (Right to Buy)
Apr 04, 2023 Sell 8 721 Martins Ryan Common Stock
Mar 31, 2023 Buy 7 500 Martins Ryan Common Stock
Mar 31, 2023 Sell 2 594 Martins Ryan Common Stock
Mar 31, 2023 Buy 5 833 Martins Ryan Common Stock
Mar 31, 2023 Sell 2 018 Martins Ryan Common Stock
Mar 31, 2023 Buy 33 333 Palekar Rohan Common Stock
Mar 31, 2023 Sell 15 443 Palekar Rohan Common Stock
Mar 31, 2023 Buy 8 333 Mansbach Harry H Common Stock
Mar 31, 2023 Sell 2 882 Mansbach Harry H Common Stock
Mar 31, 2023 Buy 3 750 Le-nguyen Quoc Common Stock
Mar 31, 2023 Buy 8 333 Le-nguyen Quoc Common Stock
Mar 31, 2023 Sell 1 297 Le-nguyen Quoc Common Stock
Mar 31, 2023 Sell 2 882 Le-nguyen Quoc Common Stock
Mar 28, 2023 Buy 61 538 Hayden Michael R Common Stock
Mar 24, 2023 Buy 2 461 538 Ra Capital Management, L.p. Common Stock
Mar 23, 2023 Sell 5 000 Martins Ryan Common Stock
Feb 09, 2023 Buy 27 400 Ra Capital Management, L.p. Stock Option (Right to Buy)
Apr 25, 2022 Buy 10 000 Hayden Michael R Common Stock
Apr 07, 2022 Buy 10 000 Hayden Michael R Common Stock
Mar 30, 2022 Buy 6 250 Hayden Michael R Common Stock
INSIDER POWER
34.681
Last 100 transactions
Buy: 8 717 496 | Sell: 3 336 793 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 34.681.

In total, the insiders bought 8 717 496 and sold 3 336 793 ETNB shares in the last 100 trades.

Click to get the best stock tips daily for free!

About 89bio, Inc.

89bio. 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorpor... ETNB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT